Matthias Leuenberger

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.

International Bar Association operates as a non profit organization of legal practitioners, bar associations and law societies. It operates various divisions that include Legal Practice and Public and Professional Interest. The company was founded in 1947 and is headquartered in London, the United Kingdom.

LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Part of Geberit AG, Geberit International AG is a leading European provider of bathroom and plumbing products. The company is based in Rapperswil-Jona, Switzerland. The Swiss company specializes in both bathroom ceramics and sanitary technology, offering unique value to customers through its strong local presence. The company was founded in 1874 by Caspar Melchior Albe Gebert. Christian Buhl has been the CEO of the company since 2015.

Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.

HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland.

Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA.

Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland.

Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland.

Part of Novartis AG, Novartis Grimsby Ltd. is a British healthcare company that focuses on clinical trials to bring innovative medicines to patients with various diseases or conditions. The company is based in Camberley, UK and provides solutions to address the evolving needs of patients worldwide. Novartis Grimsby also partners with patient groups and sponsors the Future Talent Programme page. Founded in 1920, the company has a pipeline of over 200 projects in clinical development, many of which could advance treatment standards for patients.

SwissHoldings operates as a business federation representing the interests of Swiss based multinational enterprises from the manufacturing and service sectors. The company is headquartered in Bern, Switzerland.

Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow.

Part of Vetter Pharma-Fertigung Verwaltungs GmbH, Vetter Pharma International GmbH is a pharmaceutical service provider that offers comprehensive fill-and-finish services from clinical development to commercialization and beyond. The company is based in Ravensburg, Germany. The German company uses robust, well-controlled testing procedures to verify the quality of every product they release. Vetter is a family-owned company that provides expert manufacturing guidance for injectable drug products. The company has an exclusive collection of in-depth videos that customers can explore. Recently, they responded to increasing market demand by implementing additional equipment for aseptic production and expanding storage capacities at the clinical site. The company was founded in 2009, and the CEO is Peter Sölkner.

Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017.

Swiss Fintech AG is a leading debt capital market platform that provides financing solutions for municipalities, cities, cantons, large companies, banks, and insurance companies. The company is based in Zurich, Switzerland and was founded by Andi Burri, Dario Zogg, Stefan Muehlemann. The Swiss company has over 3,000 customers and the largest investor network in Switzerland. With Loanboox Real Estate, the company also offers financing solutions for real estate companies. The company has 50 dedicated, experienced, and visionary employees in 5 countries. The team of Loanboox experts helps customers to find the best debt capital planning and financing strategies. The CEO is Philippe Cayrol.

Part of HeiQ Plc, Chrisal NV is a Belgian company that develops industrial biotechnologies and products. The company is based in Lommel, Belgium. The company was founded in 1989 by Corrie Gielen. The CEO is Cornelis Gielen. Chrisal was acquired by HeiQ Plc on April 28, 2021 for $9.05 million.

Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021.

E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany.